Ledger.Open graph →
SEC Form D · Amendment · filed December 13, 2022

Trio Pharmaceuticals, Inc

Offering
$2.4M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Other
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Shivarupam Bhowmik · San Diego, CAExec · DirectorJeffrey Friedman · San Diego, CADirectorReiner Laus · San Diego, CAExec · DirectorPeter K. Zarifes · Pasadena, CAExec · DirectorSteven A. Anderson · Pasadena, CAExec · DirectorJames G. Ellis · Pasadena, CADirectorKathleen J. Scott · San Diego, CAExec · DirectorKyri K. Van Hoose · San Diego, CAExec · DirectorBrittany J. Bradrick · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗